Patents Assigned to EIP Pharma, Inc.
  • TREATMENT OF GAIT DYSFUNCTION IN NEURODEGENERATIVE DISEASE
    Publication number: 20230405005
    Abstract: The present invention provides methods and compositions for treatment of gait dysfunction in subjects with neurodegenerative disease of the cholinergic forebrain. In some embodiments, methods are provided for treatment of gait dysfunction related to an alpha synuclein disease, such as Parkinson's disease (PD) or Dementia with Lewy Bodies (DLB).
    Type: Application
    Filed: November 5, 2021
    Publication date: December 21, 2023
    Applicant: EIP Pharma, Inc.
    Inventor: John Jahangir Alam
  • COMPOSITIONS AND METHODS FOR TREATING PRION DISEASE
    Publication number: 20220387432
    Abstract: The present invention provides methods and compositions for treatment of prion disease.
    Type: Application
    Filed: September 18, 2020
    Publication date: December 8, 2022
    Applicants: EIP Pharma, Inc., Trustees of Boston University
    Inventors: John Jahangir Alam, David A. Harris, Cheng Fang
  • COMPOSITIONS AND METHODS FOR TREATING BASAL FOREBRAIN DISEASE
    Publication number: 20220133729
    Abstract: The present invention provides methods and compositions for treatment of Dementia with Lewy Bodies.
    Type: Application
    Filed: January 11, 2022
    Publication date: May 5, 2022
    Applicant: EIP Pharma, Inc.
    Inventor: John Jahangir Alam
  • COMPOSITIONS AND METHODS FOR TREATING DEMENTIA WITH LEWY BODIES
    Publication number: 20210077497
    Abstract: The present invention provides methods and compositions for treatment of Dementia with Lewy Bodies.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Applicant: EIP Pharma, Inc.
    Inventor: John Jahangir Alam